BR112018002283A2 - Composição para administração tópica a um sujeito, e, formulação tópica - Google Patents
Composição para administração tópica a um sujeito, e, formulação tópicaInfo
- Publication number
- BR112018002283A2 BR112018002283A2 BR112018002283A BR112018002283A BR112018002283A2 BR 112018002283 A2 BR112018002283 A2 BR 112018002283A2 BR 112018002283 A BR112018002283 A BR 112018002283A BR 112018002283 A BR112018002283 A BR 112018002283A BR 112018002283 A2 BR112018002283 A2 BR 112018002283A2
- Authority
- BR
- Brazil
- Prior art keywords
- topical
- subject
- composition
- formulation
- administration
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 238000011200 topical administration Methods 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562201380P | 2015-08-05 | 2015-08-05 | |
| US62/201,380 | 2015-08-05 | ||
| PCT/US2016/045258 WO2017023977A1 (en) | 2015-08-05 | 2016-08-03 | Antimicrobial compositions comprising mupirocin and neomycin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018002283A2 true BR112018002283A2 (pt) | 2018-10-02 |
| BR112018002283B1 BR112018002283B1 (pt) | 2023-12-12 |
Family
ID=56686925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018002283-7A BR112018002283B1 (pt) | 2015-08-05 | 2016-08-03 | Composição para administração tópica a um sujeito, e, formulação tópica |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10525032B2 (pt) |
| EP (1) | EP3331496B1 (pt) |
| JP (1) | JP6783476B2 (pt) |
| CN (1) | CN108348453B (pt) |
| AU (1) | AU2016301247B2 (pt) |
| BR (1) | BR112018002283B1 (pt) |
| CA (1) | CA2993999C (pt) |
| ES (1) | ES2856798T3 (pt) |
| HK (1) | HK1254365A1 (pt) |
| MX (1) | MX2018001512A (pt) |
| WO (1) | WO2017023977A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019519487A (ja) | 2016-05-05 | 2019-07-11 | アクエスティブ セラピューティクス インコーポレイテッド | 送達増強エピネフリン組成物 |
| BR112020005967A2 (pt) * | 2017-09-27 | 2020-10-06 | Aquestive Therapeutics, Inc. | composições farmacêuticas com permeação realçada |
| GB2589286A (en) * | 2019-07-22 | 2021-06-02 | Helperby Therapeutics Ltd | Method |
| CN110787128A (zh) * | 2019-12-17 | 2020-02-14 | 福元药业有限公司 | 一种莫匹罗星软膏及其制备方法 |
| KR102334452B1 (ko) | 2020-05-29 | 2021-12-03 | 코스맥스 주식회사 | 코리네박테리움 우레아리티쿰 균주 및 그의 피부 상태 개선 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517852B2 (en) | 2005-07-28 | 2009-04-14 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
| KR101367479B1 (ko) * | 2008-07-21 | 2014-03-14 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법 |
| SI2600869T1 (sl) | 2010-08-05 | 2021-03-31 | Helperby Therapeutics Limited | Kombinacija spojine pirolokinolin in beta-laktamskega protimikrobnega sredstva, mupirocina in klorheksidina |
| US8481591B2 (en) * | 2010-11-01 | 2013-07-09 | Stiefel Research Australia Pty. Ltd. | Polymeric topical compositions |
-
2016
- 2016-08-03 US US15/749,578 patent/US10525032B2/en active Active
- 2016-08-03 CA CA2993999A patent/CA2993999C/en active Active
- 2016-08-03 AU AU2016301247A patent/AU2016301247B2/en active Active
- 2016-08-03 WO PCT/US2016/045258 patent/WO2017023977A1/en active Application Filing
- 2016-08-03 ES ES16751742T patent/ES2856798T3/es active Active
- 2016-08-03 CN CN201680057966.6A patent/CN108348453B/zh active Active
- 2016-08-03 MX MX2018001512A patent/MX2018001512A/es unknown
- 2016-08-03 JP JP2018505713A patent/JP6783476B2/ja active Active
- 2016-08-03 EP EP16751742.4A patent/EP3331496B1/en active Active
- 2016-08-03 BR BR112018002283-7A patent/BR112018002283B1/pt active IP Right Grant
-
2018
- 2018-10-19 HK HK18113441.8A patent/HK1254365A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180228760A1 (en) | 2018-08-16 |
| JP6783476B2 (ja) | 2020-11-11 |
| AU2016301247B2 (en) | 2021-05-27 |
| AU2016301247A1 (en) | 2018-03-15 |
| EP3331496B1 (en) | 2021-01-27 |
| WO2017023977A1 (en) | 2017-02-09 |
| EP3331496A1 (en) | 2018-06-13 |
| HK1254365A1 (zh) | 2019-07-19 |
| US10525032B2 (en) | 2020-01-07 |
| CN108348453A (zh) | 2018-07-31 |
| CA2993999C (en) | 2023-07-25 |
| CN108348453B (zh) | 2021-09-03 |
| JP2018522048A (ja) | 2018-08-09 |
| MX2018001512A (es) | 2018-08-01 |
| CA2993999A1 (en) | 2017-02-09 |
| ES2856798T3 (es) | 2021-09-28 |
| BR112018002283B1 (pt) | 2023-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282304A (en) | Pharmaceutical preparations for local use | |
| FR21C1059I2 (fr) | Compositions pharmaceutiques | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| BR112017020358A2 (pt) | composição farmacêutica de tetraciclina para uso dermatológico | |
| BR112016021011A2 (pt) | composição tópica e usos de um composto | |
| DK3043778T3 (da) | Farmaceutiske sammensætninger, der indeholder refametinib | |
| BR112016025659A2 (pt) | compostos, seus usos, e composições farmacêuticas para induzir condrogênese | |
| BR112018002283A2 (pt) | Composição para administração tópica a um sujeito, e, formulação tópica | |
| HK1231390A1 (zh) | 用於局部給藥的藥用組合物 | |
| DK3229776T3 (da) | Farmaceutisk sammensætning, der kombinerer mindst to særskilte nanopartikler og en farmaceutisk forbindelse, fremstilling og anvendelser deraf | |
| SG11201706938XA (en) | Topical formulation | |
| GB201320932D0 (en) | Topical pharmaceutical composition | |
| GB201502845D0 (en) | Topical pharmaceutical formulation | |
| ES2981002T3 (es) | Formulación farmacéutica | |
| BR112016030507A2 (pt) | Compostos relacionados à vitamina d, composição farmacêutica, e kit | |
| BR112016021875A2 (pt) | composição tópica | |
| EP3095453A4 (en) | Topical agent for transdermal administration | |
| DK3369429T3 (da) | Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden | |
| DK3265429T3 (da) | Nanopartikler til anvendelse som hæftningscentre i superledere | |
| IL261929B (en) | Stable pharmaceutical preparations for topical administration and their use | |
| HK1256152A1 (zh) | 包含局部用藥物的蓋侖製劑 | |
| IL255635A (en) | Antiviral pharmaceutical composition for topical use | |
| GB201609968D0 (en) | Topical pharmaceutical formulation | |
| TR201512960A1 (tr) | Topi̇kal formülasyonlar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/08/2016, OBSERVADAS AS CONDICOES LEGAIS |